Espoo, Finland

Karai Alitalo

This inventor holds 1 USPTO granted patent. Top assignees: Ludwig Institute for Cancer Research Limited, Orion Corporation. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karai Alitalo. Retrieved from https://idiyas.com/inventor/karai-alitalo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 36(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Karai Alitalo

Introduction

Karai Alitalo is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies targeting specific receptors. His work has implications for cancer research and treatment.

Latest Patents

Karai Alitalo holds a patent for "Antibodies to Flt4, a receptor tyrosine kinase and uses thereof." This invention provides purified Flt4 receptor tyrosine kinase polypeptides and fragments, along with polynucleotides encoding these polypeptides. The patent also includes antibodies that specifically bind to these polypeptides, highlighting their potential uses in medical applications.

Career Highlights

Throughout his career, Alitalo has worked with prominent organizations, including Orion Corporation and the Ludwig Institute for Cancer Research Limited. His experience in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.

Collaborations

Some of his notable coworkers include Olga Aprelikova and Katri Pajusola, who have collaborated with him on various projects in the field of cancer research.

Conclusion

Karai Alitalo's innovative work in biotechnology and his patent on Flt4 receptor antibodies demonstrate his commitment to advancing medical science. His contributions continue to influence the field and pave the way for future research and development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…